Integrated pan-cancer multi-omics profiling and experimental validation identify LSM12 as a prognostic biomarker and candidate therapeutic target in human cancers.
Saved in:
| Title: | Integrated pan-cancer multi-omics profiling and experimental validation identify LSM12 as a prognostic biomarker and candidate therapeutic target in human cancers. |
|---|---|
| Authors: | Eldeen MA; Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, 02447, Republic of Korea. dr.muhammadalaa@gmail.com.; ²Division of Computational Genomics and Precision Medicine, EdigenomiX Research Academy, EdigenomiX Scientific Ltd, Zagazig, 44519, Sharqia Governorate, Egypt. dr.muhammadalaa@gmail.com., Refaat AM; Zoology Department, Faculty of Science, Minia University, El-Minia, 61519, Egypt.; Graduate School of Biostudies, Kyoto University, Kyoto, Japan., Ahmed HEM; Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Benha University, Benha, Egypt.; Basic Medical Sciences Department, Aqaba Medical Sciences University, Aqaba, Jordan., Hassan HM; 7Department of Pathology, College of Medicine, King Khalid University, Abha, Saudi Arabia., Alshehri M; Department of Child Health, College of Medicine, King Khalid University, Abha, Saudi Arabia., Fayad E; Department of Biotechnology, College of Sciences, Taif University, Taif, 21944, Saudi Arabia., Jafri I; Department of Biotechnology, College of Sciences, Taif University, Taif, 21944, Saudi Arabia., Alshaya DS; Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, 11671, Saudi Arabia., Babteen NA; Department of Biological Sciences, College of Science, University of Jeddah, Jeddah, Saudi Arabia., Sait LM; Biological Sciences Department, College of Science & Arts, King Abdulaziz University, Rabigh, 21911, Saudi Arabia., Alqahtani LS; Department of Biological Sciences, College of Science, University of Jeddah, Jeddah, Saudi Arabia., Kim B; Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, 02447, Republic of Korea. bongleekim@khu.ac.kr.; Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul, 02447, Republic of Korea. bongleekim@khu.ac.kr.; Samuiwon Startup Center Kyung Hee University, Dr. B Lab Co., Ltd. Room 513, Seoul, 02447, Democratic People's Republic of Korea. bongleekim@khu.ac.kr.; Medical Convergence Research Center, Kyung Hee University Hospital at Gangdong, 23 Kyungheedae-ro, Gangdong-gu, Seoul , 05238, Korea, Republic of (South Korea). bongleekim@khu.ac.kr. |
| Source: | BMC cancer [BMC Cancer] 2026 Jun 23; Vol. 26 (1). Date of Electronic Publication: 2026 Jun 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
